Loading...
UK Trademark — IPO
LISEMID
Application UK00917866699 · Registered
Quick Facts
| Application Number | UK00917866699 |
| Status | Registered |
| Owner | AFLOFARM Farmacja Polska Sp. z o.o. |
| Filed | 2018-02-28 |
| Registered | 2018-06-28 |
| Renewal Due | 2028-02-28 |
| Type | Individual |
| Feature | Word |
| Attorney | See claim section below |
Is this trademark active?
Yes. LISEMID is currently a registered UK trademark, with renewal due on 2028-02-28. It is protected under UK intellectual property law and can be enforced against infringing uses.
Goods & Services
The specification below is taken directly from the filed record at the UK IPO for each Nice class this trademark is registered in.
Class 5 — Pharmaceuticals
Antihypertensives; Medicines for human purposes; Cardiovascular drugs for use in treating hypertension; Cardiovascular drugs used in treating congestive heart failure (CHF); Cardiovascular pharmaceuticals; Chemical preparations for pharmaceutical purposes; Pharmaceuticals; Pharmaceutical preparations for treating hypertension; Pharmaceutical preparations and substances; Medicinal preparations and substances; Cardiovascular preparations; Diuretic preparations; Medicine; Pharmaceutical preparations for the treatment of cardiovascular disease; Diuretic pharmaceutical preparations; Pharmaceutical preparations for human use; Chemico-pharmaceutical preparations.
Timeline
- Filed: 2018-02-28
- Registered: 2018-06-28
- Renewal due: 2028-02-28
About This Trademark
'LISEMID' is a registered trademark on the UK IPO register, owned by AFLOFARM Farmacja Polska Sp. z o.o.. The application (UK00917866699) was filed on 28 February 2018 and registered on 28 June 2018. The registration is set to expire on 28 February 2028.
This mark is recorded under Class 5 (pharmaceuticals & medical preparations).
The trademark is represented by Łukasz Pawlikowski AFLOFARM Farmacja Polska Sp. z o.o..
Frequently Asked Questions
Who owns UK trademark UK00917866699 ('LISEMID')?
UK trademark UK00917866699 for the mark 'LISEMID' in Class 5 is recorded on the UK IPO register as owned by AFLOFARM Farmacja Polska Sp. z o.o.. This covers one specific UK trademark record only — the same brand name may be owned by different parties in other classes, other countries, or as separate registrations.
Is UK trademark UK00917866699 currently a registered trademark?
Yes — the UK IPO records UK trademark UK00917866699 for the mark 'LISEMID' as registered.
Which goods or services does UK trademark UK00917866699 cover?
UK trademark UK00917866699 for the mark 'LISEMID' is registered in Class 5 (pharmaceuticals & medical preparations). The filed specification reads: Class 5: Antihypertensives; Medicines for human purposes; Cardiovascular drugs for use in treating hypertension; Cardiovascular drugs used in treating congestive heart failure (CHF); Cardiovascular pharmaceuticals; Chemical preparations for pharmaceutical purposes; Pharmaceuticals; Pharmaceutical preparations for tr…
When was UK trademark UK00917866699 filed?
UK trademark UK00917866699 for the mark 'LISEMID' was filed at the UK IPO on 28 February 2018 and registered on 28 June 2018.
When does UK trademark UK00917866699 need to be renewed?
UK trademark UK00917866699 for the mark 'LISEMID' is currently recorded as valid until 28 February 2028, at which point it will need to be renewed with the UK IPO to remain in force.
Who is the attorney of record for UK trademark UK00917866699?
Łukasz Pawlikowski AFLOFARM Farmacja Polska Sp. z o.o. is listed as the attorney / representative of record for UK trademark UK00917866699 for the mark 'LISEMID' on the UK IPO register.
Attorney of Record
This trademark has an attorney of record listed on the UK register. The firm has not yet claimed its listing on Trademark Dashboard.
Data Source
United Kingdom (Intellectual Property Office)
UK trademark data is supplied by the Intellectual Property Office under the Open Government Licence v3.0.
The “About This Trademark” summary and FAQ above are AI-generated from the register data shown on this page. They are factual summaries only — always verify details against the official register before making legal decisions.